Connect Biopharma Holdings Limited Effect Of Exchange Rate Changes On Cash And Cash Equivalents
Connect Biopharma Holdings Limited (CNTB) reported Effect Of Exchange Rate Changes On Cash And Cash Equivalents of -$90.00 thousand for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Cash Flow
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents · last filed 2024-09-05
CNY
| Period end | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 6 month | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month |
|---|---|---|
| 2023-06-30 | 18.39M CNY 6-K · filed 2023-09-12 | |
| 2022-12-31 | 94.99M CNY 20-F · filed 2023-04-11 | |
| 2022-06-30 | 75.44M CNY 6-K · filed 2023-09-12 | |
| 2021-12-31 | -40.34M CNY 20-F · filed 2023-04-11 | |
| 2021-06-30 | -17.06M CNY 6-K · filed 2022-09-13 | |
| 2020-12-31 | -53.43M CNY 20-F · filed 2023-04-11 | |
| 2019-12-31 | 1.37M CNY 20-F · filed 2022-03-31 |
USD
| Period end | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 6 month | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 6 month as first filed | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month as first filed |
|---|---|---|---|---|
| 2024-06-30 | -$90.00K 6-K · filed 2024-09-05 | |||
| 2023-12-31 | $18.00K 20-F · filed 2024-04-16 | |||
| 2023-06-30 | -$212.00K 6-K · filed 2024-09-05 | $2.55M 6-K · filed 2023-09-12 | ||
| 2022-12-31 | -$858.00K 20-F · filed 2024-04-16 | $13.64M 20-F · filed 2023-04-11 | ||
| 2022-06-30 | $11.24M 6-K · filed 2022-09-13 | |||
| 2021-12-31 | $224.00K 20-F · filed 2024-04-16 | -$6.33M 20-F · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |